Dr. Wesley W. Bryan, MD
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Tulane University School of Medicine (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 340
Licensed in Alabama since 2026, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: Tulane University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
AL license 55070 (first issued 2026; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- West Jefferson Medical Center Marrero, LA
Medical groups
- New Orleans Physician Services Inc (178 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 340
- Services billed
- 1,453
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Automated urinalysis test | 405 | 235 |
| Established patient office or other outpatient visit, 20-29 minutes | 160 | 130 |
| Established patient office or other outpatient visit, 30-39 minutes | 136 | 99 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 117 | 63 |
| Ultrasound measurement of bladder capacity after voiding | 63 | 49 |
| New patient office or other outpatient visit, 30-44 minutes | 54 | 54 |
| Diagnostic exam of bladder and urethra using an endoscope | 38 | 34 |
| New patient office or other outpatient visit, 45-59 minutes | 37 | 37 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 28 | 24 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 23 | 22 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Dothan, AL | 830 |
| Myrbetriq (mirabegron) Other prescribers in Dothan, AL | 202 |
| Finasteride Other prescribers in Dothan, AL | 201 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Dothan, AL | 188 |
| Gemtesa (vibegron) Other prescribers in Dothan, AL | 170 |
| Testosterone Cypionate Other prescribers in Dothan, AL | 170 |
| Solifenacin Succinate Other prescribers in Dothan, AL | 136 |
| Bethanechol Chloride Other prescribers in Dothan, AL | 117 |
| Ciprofloxacin Hcl Other prescribers in Dothan, AL | 114 |
| Tolterodine Tartrate Er (tolterodine tartrate) Other prescribers in Dothan, AL | 66 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 54 payments worth $2,220 in total to this clinician.
| Coloplast Corp | $840 |
|---|---|
| Calyxo, Inc. | $376 |
| Janssen Biotech, Inc. | $212 |
| Sumitomo Pharma America, Inc. | $150 |
| Boston Scientific Corporation | $117 |
| Pfizer Inc. | $79.75 |
| Bayer HealthCare Pharmaceuticals Inc. | $77.09 |
| Antares Pharma, Inc. | $46.88 |
| Food and Beverage | $2,115 |
|---|---|
| Education | $105 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Oct 28, 2025 | Education ERLEADA · Oncology · in-kind | $99.99 |
| Sumitomo Pharma America, Inc. Mar 31, 2025 | Education GEMTESA · UROLOGY · in-kind | $4.85 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.